Literature DB >> 2976766

Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?

M P Cohen.   

Abstract

Nonenzymatic glycation of proteins is one of several theories advanced in recent years to explain the pathogenesis of complications of diabetes. It is a condensation reaction between glucose and free amino groups, and the extent of glycation is largely dependent on the glucose concentration to which the protein is exposed and the biologic half-life of the involved protein. Because the lesions of diabetic microangiopathy involve basement membranes, many of the relevant studies have examined the consequences of excess glycation in collagen and other extracellular matrix proteins. Additionally, recent work indicates that glycated proteins, through a series of rearrangement reactions, give rise to abnormal cross links and complexes that are believed to alter structure-function properties and to have pathophysiologic importance. From these studies, a two-tiered scheme for the natural history of nonenzymatic glycation is proposed. This scheme is clinically relevant, particularly with respect to diabetic management programs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976766     DOI: 10.1016/s0891-6632(88)80012-6

Source DB:  PubMed          Journal:  J Diabet Complications        ISSN: 0891-6632


  12 in total

1.  Basic performance of an enzymatic method for glycated albumin and reference range determination.

Authors:  Takuji Kohzuma; Tamotsu Yamamoto; Yumiko Uematsu; Zak K Shihabi; Barry I Freedman
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

Review 2.  Painful connections: densification versus fibrosis of fascia.

Authors:  Piero G Pavan; Antonio Stecco; Robert Stern; Carla Stecco
Journal:  Curr Pain Headache Rep       Date:  2014

3.  Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus.

Authors:  S Suzuki; M Koga; S Amamiya; A Nakao; K Wada; K Okuhara; S Hayano; A R Sarhat; H Takahashi; K Matsuo; Y Tanahashi; K Fujieda
Journal:  Diabetologia       Date:  2011-06-05       Impact factor: 10.122

4.  Chokeberry juice supplementation in type 2 diabetic patients - impact on health status.

Authors:  Milica Milutinovic; Radmila Velickovic Radovanovic; Katarina Savikin; Sasa Radenkovic; Marjan Arvandi; Milica Pesic; Milica Kostic; Bojana Miladinovic; Suzana Brankovic; Dusanka Kitic
Journal:  J Appl Biomed       Date:  2019-11-13       Impact factor: 1.797

5.  Age-Adjusted Glycated Albumin at Diagnosis is more Correlated with the Product of Age and Plasma Glucose than Plasma Glucose Alone in Patients with Neonatal Diabetes Mellitus.

Authors:  Akiko Furuya; Shigeru Suzuki; Miho Oshima; Satoshi Amamiya; Atsushi Nakao; Mariko Araki; Kayo Mizutani; Satoshi Hayano; Katsumi Ushijima; Aya Imamoto; Nobuhiko Nagano; Tatsuhiko Urakami; Kumihiro Matsuo; Yusuke Tanahashi; Hiroshi Azuma; Masafumi Koga
Journal:  J Clin Lab Anal       Date:  2016-04-28       Impact factor: 2.352

6.  Increased collagen around deformed finger nailfold capillaries in type I diabetes mellitus.

Authors:  D Chen; A Studer; O Lütolf; T Schaffner; F Mahler
Journal:  Klin Wochenschr       Date:  1991-11-15

7.  Shortened mean erythrocyte age in female patients with type 2 diabetes mellitus.

Authors:  Masafumi Koga; Shinya Inada; Hiroko Ijima; Hideaki Jinnouchi; Yasuhiro Ono; Tsuyoshi Iwasaka; Toshika Okumiya
Journal:  J Clin Lab Anal       Date:  2018-10-18       Impact factor: 2.352

8.  Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia.

Authors:  Masafumi Koga; Jun Murai; Hiroshi Saito; Mikio Mukai; Soji Kasayama
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

9.  Prediction of near-future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes.

Authors:  Masafumi Koga; Jun Murai; Hiroshi Saito; Soji Kasayama
Journal:  J Diabetes Investig       Date:  2011-08-02       Impact factor: 4.232

10.  Estimation of Duration of Symptoms in Fulminant Type 1 Diabetes Mellitus Using HbA1c or Glycated Albumin.

Authors:  Akitsu Kawabe; Takashi Seta; Sumie Fujii; Masayo Yamada; Shogo Oki; Jun Murai; Hiroshi Saito; Masafumi Koga
Journal:  Jpn Clin Med       Date:  2012-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.